| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.11 | 0.7 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |